Liquidia (LQDA) Change in Cash (2020 - 2026)
Liquidia's (LQDA) quarterly Change in Cash came in at $32.1 million in Q1 2026, up 577.7% year-on-year from $4.7 million in Q1 2025, and down 3.25% quarter-over-quarter from $33.2 million in Q4 2025.
Liquidia (LQDA) Change in Cash (2020 - 2026) Analysis & Trends
Liquidia's Change in Cash history runs 7 years deep, the most recent figure standing at $32.1 million for Q1 2026.
- On a quarterly basis, Change in Cash rose 577.7% year-over-year to $32.1 million in Q1 2026; TTM through Mar 2026 was $56.5 million, a 375.06% increase from a year earlier, with the FY2025 full-year figure at $17.7 million, down 80.92% from the prior year.
- Change in Cash fell to $32.1 million in Q1 2026 per LQDA's latest filing, from $33.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $74.2 million in Q1 2024 and bottomed at -$27.9 million in Q4 2024.
- The 5-year median for Change in Cash is $300000.0 (2022), against an average of $9.9 million.
- Biggest YoY gain for Change in Cash was 6470.33% in 2024; the steepest drop was 474.15% in 2024.
- Year by year, Change in Cash stood at -$5.0 million in 2022, then surged by 247.98% to $7.5 million in 2023, then tumbled by 474.15% to -$27.9 million in 2024, then surged by 218.99% to $33.2 million in 2025, then declined by 3.25% to $32.1 million in 2026.
- Per Business Quant, the three latest LQDA Change in Cash figures stand at $32.1 million (Q1 2026), $33.2 million (Q4 2025), and -$15.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 32.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.11 Mn |
| Dec 31, 2025 | 33.18 Mn |
| Sep 30, 2025 | -15.93 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | -6.72 Mn |
| Dec 31, 2024 | -27.89 Mn |
| Sep 30, 2024 | 71.28 Mn |
| Jun 30, 2024 | -24.77 Mn |
| Mar 31, 2024 | 74.18 Mn |
| Dec 31, 2023 | 7.45 Mn |
| Sep 30, 2023 | -11.97 Mn |
| Jun 30, 2023 | -6.22 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | -5.04 Mn |
| Sep 30, 2022 | -5.52 Mn |
| Jun 30, 2022 | 46.05 Mn |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | -6.56 Mn |
| Sep 30, 2021 | -3.84 Mn |
| Jun 30, 2021 | 14.25 Mn |